22 Feb 2024 | 12:54 PM UTC
Kyrgyzstan: Elevated measles activity reported nationwide, with Bishkek most affected, in February
Elevated measles outbreak reported nationwide in Kyrgyzstan, especially Bishkek, in February. Confirm vaccination.
International health officials have reported elevated measles activity nationwide in Kyrgyzstan, with a total of 3,570 cases reported Jan. 1-Feb. 19. This is compared to the 41 cases of measles reported over a similar period in 2023. Bishkek (1,023 cases) is most affected, followed by the Chui region (849 cases), Jalal-Abad region (723 cases), Osh region (552 cases), the city of Osh (193 cases), Batken region (69 cases), Issyk-Kul region (61 cases), and Naryn region (37 cases). Local health officials have implemented outbreak response measures, including strengthening routine immunization, vaccinating all contacts, and conducting training among teachers and medical workers in Bishkek and affected regions. This report represents the most complete data available as of Feb. 22.
Visit a doctor to ensure vaccination against measles or immunity through previous infection. Practice basic health precautions. Call your medical provider if symptoms develop within three weeks of being in affected areas.
Measles vaccination coverage in Kyrgyzstan was estimated at 94 percent in 2022, which falls within the 92-95 percent required to prevent wider community transmission. Health authorities reported 7,046 measles cases nationwide in 2023, 23 cases nationwide in 2022, 3 cases in 2021, and 733 cases in 2020.
Measles is a very contagious viral disease that spreads through respiratory droplets created when an infected individual coughs, sneezes or speaks. Infected individuals can also expose people around them by contaminating surfaces with secretions from the nose, mouth, and throat. Symptoms typically appear 7-14 days after exposure but can develop up to 21 days after exposure. Symptoms generally include fever, cough, runny nose, red eyes, and a red rash that begins on the face and spreads downward. Serious complications - including pneumonia - can occur, especially in children younger than five years old, adults older than 20 years old, and individuals with a weakened immune system.
